BDNF may play a differential role in the protective effect of the mGluR2/3 agonist LY379268 on striatal projection neurons in R6/2 Huntington's disease mice

Brain Research

Volumn 1473, Issue , 2012, Pages 161-172

  Reiner, A ^a   Wang, H B ^a   Del Mar, N ^a   Sakata, K ^a   Yoo, W ^a   Deng, Y P ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

BDNF; Huntington's disease; mGluR2 3; Striatum; Therapy

Indexed keywords

4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; SUBSTANCE P;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; HISTOCHEMISTRY; HUNTINGTON CHOREA; IN SITU HYBRIDIZATION; IN SITU HYBRIDIZATION HISTOCHEMISTRY; MOUSE; NEUROPROTECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

AMINO ACIDS; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; HUNTINGTON DISEASE; IN SITU HYBRIDIZATION; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 84865496594     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.07.026     Document Type: Article

References (78)

1. K. Aggerman, and P. Ernfors Differential influence of BDNF and NT3 on the expression of calcium binding proteins and neuropeptide Y in vivo NeuroReport 14 2003 2183 2187
2. T. Aid, A. Kazantseva, M. Piirsoo, K. Palm, and T. Timmusk Mouse and rat BDNF gene structure and expression revisited J. Neurosci. Res. 85 2007 525 535
3. S. Alcantara, J. Frisen, J.A. del Rio, E. Soriano, M. Barbacid, and I. Silos-Santiago TrkB signaling is required for postnatal survival of CNS neurons and protects hippocampal and motor neurons from axotomy-induced cell death J. Neurosci. 17 1997 3623 3633
4. Allen Brain Atlas. 〈http://mouse.brain-map.org/welcome.do〉.
5. C.A. Altar, C.A. Ning, T. Bliven, M. Juhasz, M. Conner, A.L. Acheson, R.M. Lindsay, and S.J. Wiegand Anterograde transport of brain-derived neurotrophic factor and its role in the brain Nature 389 1997 856 860
6. C.A. Altar, and P.S. DiStefano Neurotrophin trafficking by anterograde transport Trends Neurosci. 21 1998 433 437
7. L. Arregui, J.A. Bentez, L.F. Razgado, P. Vergara, and J. Segovia Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington's disease delays the onset of the motor phenotype Cell. Mol. Neurobiol. 31 2011 1229 1243
8. Z.C. Baquet, J.A. Gorski, and K.R. Jones Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor J. Neurosci. 24 2004 4250 4258
9. G. Battaglia, J.A. Monn, and D.D. Schoepp In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 Neurosci. Lett. 229 1997 161 164
10. G. Battaglia, M. Cannella, B. Riozzi, S. Orobello., M.L. Maat-Schieman, E. Aronica, C.L. Busceti, A. Ciarmiello, S. Alberti, E. Amico, J. Sassone, S. Sipione, V. Bruno, L. Frati, F. Nicoletti, and F. Squitieri Early defect of transforming growth factor β1 formation in Huntington's disease J. Cell. Mol. Med. 15 2011 555 571
11. M. Baydyuk, T. Russell, G.Y. Liao, K. Zang, J.J. An, L.F. Reichardt, and B. Xu TrkB receptor controls striatal formation by regulating the number of newborn striatal neurons Proc. Nat. Acad. Sci. U.S.A. 108 2011 1669 1674
12. V. Bruno, G. Battaglia, G. Casabona, A. Copani, F. Caciagli, and F. Nicoletti Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta J. Neurosci. 18 1998 9594 9600
13. V. Bruno, F.X. Sureda, M. Storto, G. Casabona, A. Caruso, T. Knopfel, R. Kuhn, and F. Nicoletti The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling J. Neurosci. 17 1997 1891 1897
14. J.M. Canals, J.R. Pineda, J.F. Torres-Peraza, M. Bosch, R. Martn-Ibanez, M.T. Munoz, G. Mengod, P. Ernfors, and J. Alberch Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease J. Neurosci. 24 2004 7727 7739
15. R.J. Carter, M.J. Hunt, and A.J. Morton Environmental stimulation increases survival in mice transgenic for exon 1 of the Huntington's disease gene Mov. Disord. 15 2000 925 937
16. E. Cattaneo, D. Rigamonti, D. Goffredo, C. Zuccato, F. Squitieri, and S. Sipione Loss of normal huntingtin function: new developments in Huntington's disease research Trends Neurosci. 24 2001 182 188
17. E. Cattaneo, C. Zuccato, and M. Tartari Normal Huntingtin function: an alternative approach to Huntington's disease Nat. Rev. Neurosci. 6 2005 919 930
18. G. Clarke, R.A. Collins, B.R. Leavitt, D.F. Andrews, M.R. Hayden, C.J. Lumsden, and R.R. McInnes A one-hit model of cell death in inherited neuronal degenerations Nature 406 2000 195 199
19. G. Clarke, C.J. Lumsden, and R.R. McInnes Inherited neurodegenerative diseases: the one-hit model of neurodegeneration Hum. Mol. Genet. 10 2001 2269 2275
20. G. Clarke, and C.J. Lumsden Heterogeneous cellular environments modulate one-hit neuronal death kinetics Brain Res. Bull. 65 2005 59 67
21. C.S. Colwell, and M.S. Levine Metabotropic glutamate receptor modulation of excitotoxicity in the neostriatum: role of calcium channels Brain Res. 833 1999 234 241
22. C. Corti, G. Battaglia, G. Molinaro, B. Riozzi, A. Pittaluga, M. Corsi, M. Mugnaini, F. Nicoletti, and V. Bruno The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection J. Neurosci. 27 2007 8297 8308
23. A. Cozzi, S. Attucci, F. Peruginelli, M. Marinozzi, R. Luneia, R. Pellicciari, and F. Moroni Type 2 metabotropic glutamate (mGlu) receptors tonically inhibit transmitter release in rat caudate nucleus: in vivo studies with (2S,1′S,2′S,3′R)-2-(2′-carboxy-3′- phenylcyclopropyl) glycine, a new potent and selective antagonist Eur. J. Neurosci. 9 1997 1350 1355
24. C.H. Davies, V.R. Clarke, D.E. Jane, and G.L. Collingridge Pharmacology of postsynaptic metabotropic glutamate receptors in rat hippocampal CA1 pyramidal neurones Br. J. Pharmacol. 116 1995 1859 1869
25. Y.P. Deng, J.B. Penney, A.B. Young, R.L. Albin, K.D. Anderson, and A. Reiner Differential loss of striatal projection neurons in Huntington's disease: a quantitative immunohistochemical study J. Chem. Neuroanat. 27 2004 143 164
26. V. Di Liberto, A. Bonomo, M. Frinchi, N. Belluardo, and G. Mudo Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain Neuroscience 165 2010 863 873
27. M. D'Onofrio, L. Cuomo, G. Battaglia, R.T. Ngomba, M. Storto, A.E. Kingston, F. Orzi, A. De Blasi, P. Di Iorio, F. Nicoletti, and V. Bruno Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways J. Neurochem. 78 2001 435 445
28. I. Dragatsis, D. Goldowitz, N. Del Mar, Y.P. Deng, C.A. Meade, L. Liu, Z. Sun, P. Dietrich, J. Yue, and A. Reiner CAG repeat lengths <335 attenuate the phenotype in the R6/2 Huntington's disease transgenic mouse Neurobiol. Dis. 33 2009 315 330
29. D. Drai, and I. Golani SEE: a tool for the visualization and analysis of rodent exploratory behavior Neurosci. Biobehav. Rev. 25 2001 409 426
30. D. Drai, Y. Benjamini, and I. Golani Statistical discrimination of natural modes of motion in rat exploratory behavior J. Neurosci. Methods 96 2000 119 131
31. G. Figueredo-Cardenas, K.D. Anderson, Q. Chen, C.L. Veenman, and A. Reiner Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats Exp. Neurol. 129 1994 37 56
32. L.R. Gauthier, B. Charrin, M. Borrell-Pages, J. Dompierre, H. Rangone, F. Cordelieres, J. De Mey, M. MacDonald, and H.S. Lessmann Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules Cell 118 2004 127 138
33. K. Gharami, Y. Xie, J.J. An, S. Tonegawa, and B. Xu BDNF over expression in the forebrain ameliorates Huntington's disease phenotypes in mice J. Neurochem. 105 2008 369 379
34. A. Giralt, O. Carretn, C. Lao-Peregrin, E.D. Martn, and J. Alberch Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction Mol. Neurodegen 6 2011 71 86
35. J.A Gorski, S.R. Zeiler, S. Tamowski, and K.R. Jones Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites J. Neurosci. 23 2003 6856 6865
36. G. Grosse, S. Djalali, D.R. Deng, M. Holtje, B. Hinz, K. Schwartzkopff, M. Cygon, T. Rothe, T. Stroh, R. Hellweg, G. Ahnert-Hilger, and H. Hortnagl Area-specific effects of brain-derived neurotrophic factor (BDNF) genetic ablation on various neuronal subtypes of the mouse brain Dev. Brain Res. 156 2005 111 126
37. E. Hockly, B. Woodman, A. Mahal, C.M. Lewis, and G. Bates Standardization and statistical approaches to therapeutic trials in the R6/2 mouse Brain Res. Bull. 61 2003 469 479
38. S. Ivkovic, and M.E. Ehrlich Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro J. Neurosci. 19 1999 5409 5419
39. S. Jha, B. Dong, and K. Sakata Enriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV Trans. Psychiatry 1 2011 e40 10.1038/tp.2011.33
40. A.E. King, and X.H. Liu Dual action of metabotropic glutamate receptor agonists on neuronal excitability and synaptic transmission in spinal ventral horn neurons in vitro Neuropharmacol 35 1996 1673 1680
41. A.E. Kingston, M.J. O'Neill, A. Lam, K.R. Bales, J.A. Monn, and D.D. Schoepp Neuroprotection by metabotropic glutamate receptor agonists: LY2354740, LY379268 and LY389795 Eur. J. Pharmacol. 377 1999 155 165
42. V. Lessmann, K. Gottmann, and M. Malcangio Neurotrophin secretion: current facts and future prospects Prog. Neurobiol. 69 2003 341 374
43. X.B. Liu, A. Munoz, and E.G. Jones Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus J. Comp. Neurol. 395 1998 450 465
44. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 4 2001 402 408
45. D.M. Lovinger, and B.A. McCool Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3 J. Neurophys. 73 1995 1076 1083
46. V. Maglione, P. Marchi, A. Di Pardo, S. Lingrell, M. Horkey, E. Tidmarsh, and S. Sipione Impaired ganglioside metabolism in Huntington's disease and neuroprotective role of GM1 J. Neurosci. 30 2010 4072 4080
47. A. Martnez-Serrano, and A. Bjorklund Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells J. Neurosci. 16 1996 4604 4616
48. B.A. McCool, J.P. Pin, P.F. Brust, M.M. Harpold, and D.M. Lovinger Functional coupling of rat group II metabotropic glutamate receptors to an omega-conotoxin GVIA-sensitive calcium channel in human embryonic kidney 293 cells Mol. Pharmacol. 50 1996 912 922
49. J. Miller, M. Arrasate, B.A. Shaby, S. Mitra, E. Masliah, and S. Finkbeiner Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into Huntington's disease molecular pathogenesis J. Neurosci. 30 2010 10541 10550
50. K. Mizuno, J. Carnahan, and H. Nawa Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons Dev. Biol. 165 1994 243 256
51. S. Nakanishi Molecular diversity of glutamate receptors and implications for brain function Science 258 1992 597 603
52. N. Nakao, P. Brundin, K. Funa, O. Lindvall, and P. Odin Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro Dev. Brain Res. 90 1995 92 101
53. H. Ohishi, R. Shigemoto, S. Nakanishi, and N. Mizuno Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study J. Comp. Neurol. 335 1993 252 266
54. M.M. Poo Neurotrophins as synaptic modulators Nat. Rev. Neurosci. 2 2001 24 32
55. A. Reiner, I. Dragatsis, S.O. Zeitlin, and D. Goldowitz Wild-type huntingtin plays a role in brain development and neuronal survival Mol. Neurobiol. 28 2003 259 275
56. A. Reiner, Y. Jiao, N. Del Mar, A.V. Laverghetta, and W.L. Lei Differential morphology of pyramidal-tract type and intratelencephalically- projecting type corticostriatal neurons and their intrastriatal terminals in rats J. Comp. Neurol. 457 2003 420 440
57. A. Reiner, N.M. Hart, W.L. Lei, and Y.P. Deng Corticostriatal projection neuronsdichotomous types and dichotomous functions Front. Neuroanat. 4 2010 10.3389/fnana.2010.00142 (Article 142)
58. A. Reiner, Y.P. Deng, H.B. Wang, D.C. Lafferty, N. Del Mar, K. Sakata, B. Wang, and F. Liao Striatal neuroprotection in R6/2 mice by the group 2 metabotropic glutamate receptor agonist LY379268 may be mediated by the BDNF-Akt pathway Soc. Neurosci. 2011 Abst. 557.15
59. A. Reiner, D.C. Lafferty, H.B. Wang, N. Del Mar, and Y.P. Deng The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice Neurobiol. Dis. 47 2012 75 91
60. A.J. Saylor, G.E. Meredith, M.S. Vercillo, D.S. Zahm, and J.F. McGinty BDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression Exp. Neurol. 199 2006 362 372
61. D.D. Schoepp, D.E. Jane, and J.A. Monn Pharmacological agents acting at subtypes of metabotropic glutamate receptors Neuropharmacol 38 1999 1431 1476
62. E.C. Stack, J.K. Kubilus, K. Smith, K. Cormier, S.J. Del Signore, E. Guelin, H. Ryu, S.M. Hersch, and R.J. Ferrante Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice J. Comp. Neurol. 490 2005 354 370
63. E.C. Stack, A. Dedeoglu, K.M. Smith, K. Cormier, J.K. Kubilus, M. Bogdanov, W.R. Matson, L. Yang, B.G. Jenkins, R. Luthi-Carter, N.W. Kowall, S.M. Hersch, M.F. Beal, and R.J. Ferrante Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice J. Neurosci. 27 2007 12908 12915
64. A.D. Strand, Z.C. Baquet, A.K. Aragaki, P. Holmans, L. Yang, C. Cleren, M.F. Beal, L. Jones, C. Kooperberg, J.M. Olson, and K.R. Jones Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration J. Neurosci. 27 2007 11758 11768
65. Z. Sun, N. Del Mar, C. Meade, D. Goldowitz, and A. Reiner Differential changes in striatal projection neurons in R6/2 mice transgenic for Huntington's disease Neurobiol. Dis. 11 2002 369 385
66. Z. Sun, Q. Chen, and A. Reiner Enkephalinergic but not substance P-containing striatal projection neurons lose vulnerability to quinolinic acid with age in rats Exp. Neurol. 184 2003 1034 1042
67. C.M. Testa, D.G. Standaert, A.B. Young, and J.B. Penney Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat J. Neurosci. 14 1994 3005 3008
68. R. Ventimiglia, P.E. Mather, B.E. Jones, and R.M. Lindsay The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro Eur. J. Neurosci. 7 1995 213 222
69. H.B. Wang, A.V. Laverghetta, R.F. Foehring, Y.P. Deng, Z. Sun, K. Yamamoto, W.L. Lei, Y. Jiao, and A. Reiner Single-cell RT-PCR, in situ hybridization histochemical, and immunohistochemical studies of substance P and enkephalin co-occurrence in striatal projection neurons in rats J. Chem. Neurol. 31 2006 178 199
70. S. Weiss, J.P. Pin, M. Sebben, D.E. Kemp, F. Sladeczek, J. Gabrion, and J. Bockaert Synatogenesis of cultured striatal neurons in serum-free medium: a morphological and biochemical study Proc. Nat. Acad. Sci. U.S.A. 83 1986 2238 2243
71. H.R. Widmer, and F. Hefti Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture Eur. J. Neurosci. 6 1994 1669 1679
72. Y. Xie, M.R. Hayden, and B. Xu BDNF over expression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice J. Neurosci. 30 2010 14708 14718
73. M.M. Zeron, O. Hansson, N. Chen, C.L. Wellington, B.R. Leavitt, P. Brundin, M.R. Hayden, and L.A. Raymond Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease Neuron 33 2002 849 860
74. C. Zuccato, A. Ciammola, D. Rigamonti, B.R. Leavitt, D. Goffredo, L. Conti, M.E. MacDonald, R.M. Friedlander, V. Silani, M.R. Hayden, T. Timmusk, S. Sipione, and E. Cattaneo Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 2001 493 498
75. C. Zuccato, M. Tartari, A. Crotti, D. Goffredo, M. Valenza, L. Conti, T. Cataudella, B.R. Leavitt, M.R. Hayden, T. Timmusk, D. Rigamonti, and E. Cattaneo Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes Nat. Gen. 35 2003 76 83
76. C. Zuccato, D. Liber, C. Ramos, A. Tarditi, D. Rigamonti, M. Tartari, M. Valenza, and E. Cattaneo Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery Pharmacol. Res. 52 2005 133 139
77. C. Zuccato, M. Marullo, P. Conforti, M.E. McDonald, M. Tartari, and E. Cattaneo Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease Brain Path 18 2008 225 238
78. C. Zuccato, and E. Cattaneo Role of brain-derived neurotrophic factor in Huntington's disease Prog. Neurobiol. 81 2007 294 330